top of page

Cambridge, UK based Healx, an AI powered rare disease company, announced a $47M series C financing today

  • Aug 1, 2024
  • 1 min read

Co-founder and CEO Tim Guilliams describes the investors who led the round and how it will allow Healx to advance its lead program for neurofibromatosis Type 1 into a phase 2 study.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC_IB_Stacked_logo.png

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

bottom of page